RAY1225
Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin
Guangdong Raynovent Biotech Co · Phase 1 · Active, not recruiting · Enrollment 32
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Experimental 1 | Obesity or overweight | n/r | n/r | n/r | n/r |